Pharmacists in Riverside, California


348 Pharmacists found in Riverside
female pharmacist

Dr. Vinh Bui, PHARMD


Pharmacist
19929 Lonestar Ln, Riverside, CA 92508
951-642-7669    

male pharmacist

Vivekanand Korde, CIP


Pharmacist
20861 Watkins Glen Rd, Riverside, CA 92508
951-660-5404    

female pharmacist

Vivian Van Nguyen


Pharmacist
6250 Valley Springs Pkwy, Riverside, CA 92507
951-653-2969     951-697-1005



female pharmacist

Vy Nguyen, PHARMD


Pharmacist
10800 Magnolia Ave, Riverside, CA 92505
951-353-5017     951-353-4208

female pharmacist

Dr. Vy Phuong Pham, PHARMD


Pharmacist
10800 Magnolia Ave, Riverside, CA 92505
951-353-2000    

female pharmacist

Wendy Sun



4371 Latham St Ste 100, Riverside, CA 92501
951-394-7369    

male pharmacist

Mr. William Arthur Templeman Jr., PHARM.D.


Pharmacist
10800 Magnolia Ave. Inpatient Pharmacy, Kaiser Permanente, Riverside, CA 92505
951-353-4956     951-353-3044

male pharmacist

William Woohyun Choi, PHARMD


Pharmacist
777 W Blaine St, Riverside, CA 92507
951-299-9922     951-823-8442

female pharmacist

Xiao Ma


Pharmacist
491 E Alessandro Blvd, Riverside, CA 92508
951-780-1835    

male pharmacist

Yash G Patel, PHARM D


Pharmacist
8015 Limonite Ave, Riverside, CA 92509
951-361-0263    

male pharmacist

Yin Chun Hung


Pharmacist
4790 La Sierra Ave, Riverside, CA 92505
951-688-4196     951-688-7822

female pharmacist

Ms. Zdenka Anna Manthei, PHARM.D.


Pharmacist - Pharmacotherapy
10800 Magnolia Ave, Kaiser Permanente, Mob2, 4d, Nephrology, Riverside, CA 92505
951-353-3171     951-353-5133


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.